Mark Wegter

Mark Wegter

Chief Executive Officer bij LSP Advisory BV

54 jaar
Health Technology
Finance
Consumer Services

Profiel

Mr. Mark A.
Wegter
is a Partner at EQT Life Sciences Group BV and a Managing Partner at LSP Advisory BV.
He is on the Board of Directors at PamGene BV, PamGene International BV and LSP Advisory BV.
His prime focus and responsibility within LSP is to invest in listed securities and the general management of the firm.
Prior to joining LSP, he worked as a Senior Analyst at ING Corporate and Investment Banking, covering a wide range of companies and industries to which ING had significant financial exposure.
He brings over 20 years of hands-on finance and investment experience to the LSP team.
As a Director, he plays an active role in determining the successful financing, growth and strategic direction of a suite of innovative life sciences companies across Europe.
Mr. Wegter holds a Master’s degree in Business Economics from the Erasmus University of Rotterdam.

Actieve functies van Mark Wegter

BedrijvenFunctieBegin
Director/Board Member 01-12-2000
Director/Board Member 14-10-2009
Chief Executive Officer 01-01-1998
Private Equity Investor 28-02-2022
Alle actieve functies van Mark Wegter

Eerdere bekende functies van Mark Wegter

BedrijvenFunctieEinde
EURO BIOT Director/Board Member 28-02-2023
Private Equity Investor 28-02-2022
Director/Board Member 01-01-2015
Corporate Officer/Principal 01-01-2011
KIADIS PHARMA N.V. Chairman -
Ervaring van Mark Wegter in detail bekijken

Opleiding van Mark Wegter

Erasmus University Rotterdam Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Wegter in detail bekijken

Connecties

92

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit10

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Finance

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Wegter